CDEK by Data4ThePeople
Sign in Sign up
← All drugs Report issue

Galactose

Small moleculeexperimental

Galactose, sometimes abbreviated Gal, is a monosaccharide sugar that is about as sweet as glucose, and about 65% as sweet as sucrose. It is an aldohexose and a C-4 epimer of glucose. A galactose molecule linked with a glucose molecule forms a lactose molecule. — Wikipedia

Clinical trial activity

19 trials · 30 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
4
Phase 3
2
Phase 4
2

Earliest trial started Jun 1, 2004 (NCT00222040)

Timeline

2000s

  1. Jan 1, 2004

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

2010s

  1. Jan 1, 2013

    Earliest Phase 3 Sponsor(trial)

Indications

Approved for

Studied for

Mechanism of action

  • Unspecified targetSupplementation

    supplementation

Chemistry & pharmacology

Loading structure…

SMILES

OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O
Mol. weight
180.16 g/mol
Lipinski Ro5
Pass
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • alpha-d-galactopyranose
  • d-galactose
  • d-galactose
  • galactopyranose
  • galactose
  • galactose
  • galactose
  • galactose
  • galactose
  • galactose
  • galactose
  • galactose
  • levovist
  • levovist
  • levovist
  • microparticles of galactose
  • sh-ta-508
  • shu 508
  • shu-508
  • shu 508 a

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06852612N/AApr 24, 2025Medical University Innsbruck, University of Bern, University of Freiburg, University of Heidelberg, University of Zurich
NCT05986500N/ANov 1, 2023Aarhus University
NCT05402332Phase 1Jun 30, 2023Mayo Clinic
NCT05402384Phase 2/Phase 3 (Phase 3)May 31, 2023Mayo Clinic
NCT04833322N/AJan 15, 2021Hospital Ruber Internacional
NCT03903861N/AMay 31, 2019Dairy Management Inc., University of Birmingham
NCT03439878N/AFeb 1, 2018University of Bath
NCT02702765N/AFeb 1, 2016Aarhus University
NCT02528461Phase 4Jan 1, 2015Aarhus University
NCT02955264Phase 2Jul 1, 2014Tulane University
NCT03457311Phase 3Sep 9, 2013Richever Enterprise Co., Ltd.
NCT01882218Phase 4Sep 1, 2012University of Louisville
NCT02218632N/AJul 1, 2012Children's University Hospital, Ireland, Health Research Board, Ireland, Medical Research Charities Group Ireland, National University of Ireland, Trinity College Dublin
NCT01113385N/AOct 1, 2009Children's National Medical Center, National Kidney Foundation
NCT00816504Phase 1Dec 1, 2008Medical College of Wisconsin, Northwell Health
NCT00816478Phase 1Dec 1, 2008Northwell Health
NCT00814255Phase 2Dec 1, 2008National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), New York University, University of Michigan, University of Rochester
NCT00427986N/AJan 1, 2007University of Copenhagen
NCT00222040Phase 2Jun 1, 2004Government of France, University of Toulouse
Showing 19 of 19 trials
Page 1 / 1

Organizations

Research & Development (30)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Aarhus UniversityAcademic/Hospital3322015
Mayo ClinicAcademic/Hospital2222023
Northwell HealthAcademic/Hospital2212008
Children's National Medical CenterAcademic/Hospital1112009
Children's University Hospital, IrelandAcademic/Hospital1112012
Dairy Management Inc.Academic/Hospital1012019
Government of FranceGovernment1012004
Health Research Board, IrelandAcademic/Hospital1012012
Hospital Ruber InternacionalAcademic/Hospital1112021
Medical College of WisconsinAcademic/Hospital1012008
Medical Research Charities Group IrelandAcademic/Hospital1012012
Medical University InnsbruckAcademic/Hospital1012025
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Government1012008
National Kidney FoundationAcademic/Hospital1012009
National University of IrelandAcademic/Hospital1012012
New York UniversityAcademic/Hospital1112008
Richever Enterprise Co., Ltd.For profit1112013
Trinity College DublinAcademic/Hospital1012012
Tulane UniversityAcademic/Hospital1112014
University of BathAcademic/Hospital1112018
30 organizations
Page 1 / 2